Constructing a malaria-related health service readiness index and assessing its association with child malaria mortality: an analysis of the Burkina Faso 2014 SARA data

Millogo, Ourohiré; Doamba, Jean E. O.; Sié, Ali; Utzinger, Jürg; Vounatsou, Penelope

doi:10.1186/s12889-020-09994-7

Table 3 Standard coordinates of tracer items on the first 14 factorial axes (medical centres) derived from the SARA survey in 2014 in Burkina Faso.

From: Constructing a malaria-related health service readiness index and assessing its association with child malaria mortality: an analysis of the Burkina Faso 2014 SARA data

Tracers	Category	Frequency, n(%)	Factorial axes^*
Tracers	Category	Frequency, n(%)	1	2	3	4	5	6	7	8	9	10	11	12	13	14
Privacy room	No	31 (27.7)	−0.281^a	−1.196	0.358	−2.537	1.257	−1.370	−0.195	0.746	0.171	*−5.265*	−3.066	1.560	0.252	1.213
Privacy room	Yes	81 (72.3)	0.107	0.458	−0.137	0.971	−0.481	0.524	0.075	−0.285	− 0.065	*2.015*	1.173	−0.597	−0.097	− 0.464
Emergency transportation	No	6 (5.4)	0.063	−3.332	−2.716	4.195	0.012	−7.946	4.844	*−11.193*	−0.109	− 1.787	1.657	3.354	−2.609	2.616
Emergency transportation	Yes	106 (94.6)	−0.004	0.189	0.154	−0.237	−0.001	0.450	−0.274	*0.634*	0.006	0.101	−0.094	−0.190	0.148	−0.148
Light power	No	20 (17.9)	−0.925	*−3.350*^b	0.885	0.805	0.298	2.439	−4.057	−1.751	−0.649	−3.378	2.240	−4.542	−0.070	− 0.001
Light power	Yes	92 (82.1)	0.201	*0.728*	−0.192	−0.175	− 0.065	−0.530	0.882	0.381	0.141	0.734	−0.487	0.987	0.015	0.000
Safe final disposal of sharps	No	27 (24.1)	1.254	−0.656	*−4.856*	−2.973	− 0.352	0.664	− 0.421	− 0.995	1.152	− 0.588	2.051	− 0.445	− 0.888	− 0.100
Safe final disposal of sharps	Yes	85 (75.9)	−0.398	0.208	*1.542*	0.944	0.112	−0.211	0.134	0.316	−0.366	0.187	−0.652	0.142	0.282	0.032
Safe final disposal of infectious wastes	No	30 (26.8)	0.859	−0.684	*−4.958*	−2.727	0.017	0.163	−1.408	− 0.591	1.160	0.798	−0.069	0.185	−0.102	− 0.391
Safe final disposal of infectious wastes	Yes	82 (73.2)	−0.314	0.250	*1.814*	0.998	−0.006	−0.060	0.515	0.216	−0.424	−0.292	0.025	−0.068	0.037	0.143
Appropriate storage of infectious waste	No	9 (8.0)	1.198	−2.643	0.035	1.036	−1.691	*−9.057*	− 1.236	− 0.570	− 1.376	2.107	5.636	−5.990	3.825	3.190
Appropriate storage of infectious waste	Yes	103 (92.0)	−0.105	0.231	− 0.003	− 0.091	0.148	*0.791*	0.108	0.050	0.120	−0.184	−0.492	0.523	−0.334	− 0.279
Latex gloves	No	12 (10.1)	−0.252	−3.347	0.867	0.983	−4.095	−0.858	*−6.782*	3.797	−3.464	0.525	2.358	0.705	−3.537	−1.541
Latex gloves	Yes	100 (89.9)	0.030	0.402	−0.104	− 0.118	0.491	0.103	*0.814*	−0.456	0.416	−0.063	−0.283	− 0.085	0.424	0.185
Guidelines for standard precautions	No	14 (22.5)	*−3.610*	0.980	−1.949	−1.532	− 1.850	− 1.734	4.077	1.023	−2.052	− 3.909	− 0.936	− 3.326	− 1.546	1.195
Guidelines for standard precautions	Yes	98 (87.5)	*0.516*	−0.140	0.278	0.219	0.264	0.248	−0.582	− 0.146	0.293	0.558	0.134	0.475	0.221	−0.171
Haemoglobin test	No	40 (35.7)	−1.086	−1.396	−0.563	0.630	−2.200	0.331	0.568	−0.251	− 2.686	1.100	− 0.855	1.830	*−3.237*	0.473
Haemoglobin test	Yes	72 (64.3)	0.603	0.775	0.313	−0.350	1.222	−0.184	− 0.316	0.139	1.492	−0.611	0.475	−1.017	*1.798*	−0.263
Glucose dipstick	No	8 (7.1)	−2.850	0.482	−4.354	0.289	*−6.397*	2.569	3.601	4.457	−1.015	−5.601	0.354	−5.051	−0.402	− 0.182
Glucose dipstick	Yes	104 (92.9)	0.219	−0.037	0.335	−0.022	*0.492*	− 0.198	− 0.277	− 0.343	0.078	0.431	− 0.027	0.389	0.031	0.014
Amlopdipin	No	87 (77.7)	−0.329	− 0.723	0.354	− 0.378	− 0.280	− 0.416	− 0.848	0.125	1.106	0.339	− 0.459	0.036	0.424	0.184
Amlopdipin	Yes	25 (22.3)	1.144	2.515	−1.231	1.315	0.974	1.448	2.953	−0.436	− 3.848	−1.180	1.597	−0.125	− 1.477	−0.640
Aspirin	No	18 (16.1)	*−3.484*	3.093	−0.109	− 0.623	1.267	−1.229	0.818	2.121	−2.599	1.476	0.217	− 2.705	1.985	1.667
Aspirin	Yes	94 (83.9)	*0.667*	−0.592	0.021	0.119	−0.243	0.235	−0.157	− 0.406	0.498	− 0.283	− 0.042	0.518	− 0.380	− 0.319
Beclomethasone inhaler	No	98 (87.5)	−0.205	−0.683	0.214	−0.707	− 0.065	− 0.013	0.293	− 0.313	− 0.362	0.313	0.484	0.025	0.342	−0.079
Beclomethasone inhaler	Yes	14 (12.5)	1.435	4.781	−1.495	4.948	0.452	0.094	−2.052	2.190	2.536	− 2.189	−3.386	−0.177	− 2.394	0.555
Beta-blockers	No	92 (82.1)	−0.433	− 0.793	0.614	−0.473	− 0.185	0.294	0.561	− 0.134	0.132	−0.074	0.098	0.032	0.439	0.587
Beta-blockers	Yes	20 (17.9)	1.990	3.648	−2.824	2.176	0.849	−1.355	−2.581	0.616	−0.609	0.339	− 0.450	− 0.145	− 2.021	− 2.701
Ceftriaxone	No	9 (8.0)	*−6.392*	1.090	0.991	−0.869	3.199	−1.868	−2.313	−2.918	2.354	−0.844	3.647	1.036	−6.562	−1.918
Ceftriaxone	Yes	103 (92.0)	*0.558*	−0.095	− 0.087	0.076	− 0.280	0.163	0.202	0.255	−0.206	0.074	−0.319	− 0.090	0.573	0.168
Gentamicin	No	11 (9.8)	*−4.331*	−1.279	−2.234	4.478	2.838	2.256	−0.629	− 0.754	1.864	1.838	−1.003	−2.284	−0.105	6.498
Gentamicin	Yes	101 (90.2)	*0.472*	0.139	0.243	−0.488	− 0.309	− 0.246	0.069	0.082	− 0.203	− 0.200	0.109	0.249	0.011	−0.708
Glibenclamide	No	73 (65.2)	−0.724	−0.211	− 0.581	0.607	0.655	0.053	−0.176	−0.305	−1.378	− 0.786	0.346	0.540	1.845	*−1.922*
Glibenclamide	Yes	39 (34.8)	1.356	0.395	1.088	−1.137	− 1.225	− 0.099	0.329	0.571	2.580	1.471	−0.648	−1.011	−3.453	*3.598*
Insulin injectable	No	104 (92.9)	−0.123	*−0.424*	0.222	−0.186	− 0.106	−0.147	0.493	0.038	0.378	0.233	−0.339	− 0.364	− 0.207	−0.641
Insulin injectable	Yes	8 (7.1)	1.596	*5.512*	−2.880	2.420	1.375	1.909	−6.404	−0.489	−4.911	−3.035	4.404	4.737	2.688	8.330
Magnesium	No	34 (30.4)	*−2.083*	− 2.028	−0.340	1.431	0.424	0.597	−1.968	0.063	0.339	−0.313	−2.323	0.905	0.300	−0.988
Magnesium	Yes	78 (69.6)	*0.908*	0.884	0.148	−0.624	− 0.185	− 0.260	0.858	−0.028	− 0.148	0.136	1.013	−0.395	− 0.131	0.431
Oxytocin	No	14 (12.5)	*−3.089*	−0.951	−3.370	5.102	−0.779	2.837	1.260	−2.386	2.970	1.110	−1.926	− 2.982	0.951	−0.272
Oxytocin	Yes	98 (87.5)	*0.441*	0.136	0.481	−0.729	0.111	−0.405	− 0.180	0.341	− 0.424	− 0.159	0.275	0.426	− 0.136	0.039
Salbutamol	No	26 (23.2)	*−3.000*	− 0.517	−1.091	−1.330	−0.915	− 0.662	− 0.223	1.480	−2.038	1.850	− 0.362	1.727	0.879	1.003
Salbutamol	Yes	86 (76.8)	*0.907*	0.156	0.330	0.402	0.277	0.200	0.067	−0.448	0.616	− 0.559	0.109	− 0.522	− 0.266	− 0.303
Zinc	No	35 (31.3)	*−2.157*	0.502	−0.495	−0.975	0.011	2.273	0.503	−0.816	1.147	0.610	1.572	2.790	1.487	0.844
Zinc	Yes	77 (68.8)	*0.980*	−0.228	0.225	0.443	−0.005	−1.033	− 0.229	0.371	−0.522	− 0.277	− 0.715	− 1.268	− 0.676	− 0.383
ITNs	No	83 (74.1)	−0.220	0.045	−0.747	− 0.247	0.762	−1.081	−0.434	− 0.005	− 0.520	0.795	*− 1.332*	− 0.377	0.161	− 0.081
ITNs	Yes	29 (25.9)	0.628	−0.128	2.139	0.708	−2.180	3.093	1.242	0.015	1.487	−2.276	*3.811*	1.079	−0.461	0.231
Staff trained in malaria diagnosis and treatment	No	33 (29.5)	*−1.091*	1.604	−0.341	− 0.226	*−3.506*	− 0.728	− 1.149	1.928	2.217	− 0.102	0.246	0.246	1.343	−0.185
Staff trained in malaria diagnosis and treatment	Yes	79 (70 5)	*0.456*	−0.670	0.143	0.094	*1.465*	0.304	0.480	− 0.806	−0.926	0.043	− 0.103	− 0.103	− 0.561	0.077
Staff trained in intermittent preventive treatment in pregnancy (IPTp)	No	38 (33.9)	−0.158	−0.459	− 0.829	2.575	−1.426	*−2.856*	0.619	0.713	1.757	−1.492	1.060	2.415	0.922	0.162
	Yes	74 (66.1)	0.081	0.236	0.426	−1.322	0.732	*1.467*	−0.318	−0.366	− 0.902	0.766	− 0.544	−1.240	− 0.474	− 0.083
First line treatment of malaria	No	13 (11.6)	*−4.606*	2.906	0.766	−1.353	0.142	−1.435	0.786	0.550	2.369	1.904	2.504	0.379	−0.856	−4.781
First line treatment of malaria	Yes	99 (88.4)	*0.605*	−0.382	− 0.101	0.178	− 0.019	0.188	− 0.103	− 0.072	−0.311	− 0.250	−0.329	− 0.050	0.112	0.628
IPTp drug	No	50 (44.6)	*−5.589*	3.721	1.822	−2.447	5.322	−2.872	− 2.985	0.352	1.426	−2.683	3.527	−0.455	−4.909	2.079
IPTp drug	Yes	62 (55.4)	*0.430*	−0.286	− 0.140	0.188	− 0.409	0.221	0.230	−0.027	− 0.110	0.206	−0.271	0.035	0.378	−0.160
Carbamazepine	No	84 (75.0)	−0.144	0.764	0.367	−0.450	*−1.050*	0.110	−0.594	−1.146	−0.364	0.136	−0.686	0.030	0.566	0.637
Carbamazepine	Yes	28 (25.0)	0.432	−2.292	−1.101	1.349	*3.149*	−0.331	1.782	3.438	1.093	−0.408	2.057	−0.091	−1.698	−1.911
Haloperidol	No	85 (75.9)	−0.183	0.825	0.330	−0.199	− 0.894	− 0.172	− 0.410	−1.475	− 0.025	−0.361	− 0.402	− 0.354	− 0.078	− 0.660
Haloperidol	Yes	27 (24.1)	0.577	−2.599	−1.039	0.627	2.815	0.541	1.292	4.644	0.079	1.136	1.266	1.116	0.244	2.078
Inertia explained by the factorial axis (%)			14.5	8.9	6.7	6.1	5.9	5.3	4.7	4.4	4.0	3.7	3.6	3.4	3.0	2.9

^*First 14 factorial axes to build the composite readiness score as there is no information gain beyond axis 14
^aFour tracers consistent with the FAOC-G in negative direction (not bold) and 25 consistent in positive direction (bold)
^bHighlighted in bold and italic are the weights of tracers from factorial axes selected to build the composite readiness score

Back to article page

ISSN: 1471-2458

Contact us

Submission enquiries: bmcpublichealth@biomedcentral.com
General enquiries: ORSupport@springernature.com

BMC Public Health

Contact us